Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9CCH

Solution structure of the Bsu Anti-TRAP trimer

Replaces:  2KO8
Summary for 9CCH
Entry DOI10.2210/pdb9cch/pdb
NMR InformationBMRB: 16492
DescriptorAnti-TRAP regulator, ZINC ION (2 entities in total)
Functional Keywordsinhibitor, zinc ribbon, trp operon, gene regulation
Biological sourceBacillus subtilis
Total number of polymer chains3
Total formula weight17246.95
Authors
Foster, M.P.,McElroy, C.A.,Ihms, E.C.,Kumar Yadav, D. (deposition date: 2024-06-21, release date: 2025-06-25, Last modification date: 2026-01-07)
Primary citationMcElroy, C.A.,Ihms, E.C.,Kumar Yadav, D.,Holmquist, M.L.,Wadhwa, V.,Wysocki, V.H.,Gollnick, P.,Foster, M.P.
Solution structure, dynamics and tetrahedral assembly of Anti-TRAP, a homo-trimeric triskelion-shaped regulator of tryptophan biosynthesis in Bacillus subtilis.
J Struct Biol X, 10:100103-100103, 2024
Cited by
PubMed Abstract: Cellular production of tryptophan is metabolically expensive and tightly regulated. The small zinc binding Anti-TRAP protein (AT), which is the product of the gene, is upregulated in response to accumulating levels of uncharged tRNA through a T-box antitermination mechanism. AT binds to the undecameric axially symmetric ring-shaped protein TRAP ( RNA Binding Attenuation Protein), thereby preventing it from binding to the leader RNA. This reverses the inhibitory effect of TRAP on transcription and translation of the operon. AT principally adopts two symmetric oligomeric states, a trimer (AT) featuring three-fold axial symmetry or a dodecamer (AT) comprising a tetrahedral assembly of trimers, whereas only the trimeric form binds and inhibits TRAP. We apply native mass spectrometry (nMS) and small-angle x-ray scattering (SAXS), together with analytical ultracentrifugation (AUC) to monitor the pH and concentration-dependent equilibrium between the trimeric and dodecameric structural forms of AT. In addition, we use solution nuclear magnetic resonance (NMR) spectroscopy to determine the solution structure of AT, while heteronuclear N relaxation measurements on both oligomeric forms of AT provide insights into the dynamic properties of binding-active AT and binding-inactive AT, with implications for TRAP binding and inhibition.
PubMed: 39035014
DOI: 10.1016/j.yjsbx.2024.100103
PDB entries with the same primary citation
Experimental method
SOLUTION NMR
SOLUTION SCATTERING
Structure validation

248942

PDB entries from 2026-02-11

PDB statisticsPDBj update infoContact PDBjnumon